Predicta Biosciences

Unlocking Molecular Insights for Blood Cancer Care

Cambridge, United States · Founded 2023 · $28.6M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$28.6M
Last Round
$23.4M Series AOct 2025
Rounds
2

About

Predicta Biosciences is a Cambridge, MA-based precision oncology company that integrates multi-omics and liquid biopsy diagnostics to transform the diagnosis, monitoring, and treatment of blood cancers. From a single blood draw, its GenoPredicta platform delivers whole-genome sequencing of circulating tumor cells to uncover structural variants and clonal evolution that standard tests miss, while ImmunoPredicta adds single-cell immune profiling. The company also partners with biopharma firms for biomarker discovery, patient stratification, and clinical trial acceleration.

Summary

Predicta Biosciences is an Artificial Intelligence company based in Cambridge, United States, founded in 2023. It has raised $28.6M in total across 2 rounds, most recently a $23.4M Series A round in Oct 2025. Investors include Engine Ventures, The Engine and Illumina Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2025
$23.4M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Predicta Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/predicta-biosciences"><img src="https://indexed.vc/api/badge/company/predicta-biosciences" alt="Predicta Biosciences on Indexed.vc" width="260" height="76" /></a>